P. Dalivoust

520 total citations
5 papers, 61 citations indexed

About

P. Dalivoust is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, P. Dalivoust has authored 5 papers receiving a total of 61 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 1 paper in Surgery. Recurrent topics in P. Dalivoust's work include Advanced Breast Cancer Therapies (2 papers), Cancer Treatment and Pharmacology (2 papers) and HER2/EGFR in Cancer Research (1 paper). P. Dalivoust is often cited by papers focused on Advanced Breast Cancer Therapies (2 papers), Cancer Treatment and Pharmacology (2 papers) and HER2/EGFR in Cancer Research (1 paper). P. Dalivoust collaborates with scholars based in France, United States and Austria. P. Dalivoust's co-authors include Marc Debled, Manfred Kaufmann, Nicholas J. Robert, Friederike Siedentopf, Joyce O’Shaughnessy, Nadia Harbeck, Krzysztof Urbański, Mathilde Sibony, Philippe Beuzeboc and Stéphane Oudard and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Oncologist.

In The Last Decade

P. Dalivoust

5 papers receiving 59 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Dalivoust France 3 46 16 15 11 6 5 61
Judith Fraser United Kingdom 5 54 1.2× 15 0.9× 21 1.4× 6 0.5× 9 1.5× 11 70
José Rodrigo Espinosa Fernández United States 5 44 1.0× 10 0.6× 26 1.7× 17 1.5× 3 0.5× 9 68
Angelo Fedele Scinto Italy 4 49 1.1× 41 2.6× 11 0.7× 11 1.0× 6 1.0× 4 67
Laura Murillo Spain 5 48 1.0× 20 1.3× 20 1.3× 11 1.0× 2 0.3× 14 63
Samira Bensfia Spain 3 54 1.2× 15 0.9× 28 1.9× 12 1.1× 2 0.3× 9 67
G.K. Bascom United States 2 27 0.6× 8 0.5× 5 0.3× 8 0.7× 2 0.3× 2 63
Jeanna Knoble United States 6 46 1.0× 17 1.1× 8 0.5× 6 0.5× 9 1.5× 10 61
Nicolas Madranges France 7 69 1.5× 39 2.4× 22 1.5× 15 1.4× 6 1.0× 11 81
Yiu-Keung Lau United States 4 29 0.6× 20 1.3× 9 0.6× 6 0.5× 1 0.2× 10 53
Annelisa Marsella Italy 4 49 1.1× 8 0.5× 52 3.5× 10 0.9× 10 1.7× 5 92

Countries citing papers authored by P. Dalivoust

Since Specialization
Citations

This map shows the geographic impact of P. Dalivoust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Dalivoust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Dalivoust more than expected).

Fields of papers citing papers by P. Dalivoust

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Dalivoust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Dalivoust. The network helps show where P. Dalivoust may publish in the future.

Co-authorship network of co-authors of P. Dalivoust

This figure shows the co-authorship network connecting the top 25 collaborators of P. Dalivoust. A scholar is included among the top collaborators of P. Dalivoust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Dalivoust. P. Dalivoust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
O’Shaughnessy, Joyce, Manfred Kaufmann, Friederike Siedentopf, et al.. (2012). Capecitabine Monotherapy: Review of Studies in First-Line HER-2-Negative Metastatic Breast Cancer. The Oncologist. 17(4). 476–484. 50 indexed citations
2.
3.
Belle, Simon Van, et al.. (2009). CHOICE, an international, observational study to examine current practice use of darbepoetin alfa in the management of chemotherapy-induced anaemia. European Journal of Integrative Medicine. 1(4). 226–226. 2 indexed citations
4.
5.
Vieillefond, Annick, Philippe Beuzeboc, L. Mignot, et al.. (2005). HER2 status in urothelial bladder cancer (UC): screening of patients eligible for a phase II randomized study of gemcitabine plus platinum salt with or without trastuzumab. Journal of Clinical Oncology. 23(16_suppl). 4700–4700. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judith Fraser Breakdown of academic impact, for papers by José Rodrigo Espinosa Fernández Breakdown of academic impact, for papers by Angelo Fedele Scinto Breakdown of academic impact, for papers by Laura Murillo Breakdown of academic impact, for papers by Samira Bensfia Breakdown of academic impact, for papers by G.K. Bascom Breakdown of academic impact, for papers by Jeanna Knoble Breakdown of academic impact, for papers by Nicolas Madranges Breakdown of academic impact, for papers by Yiu-Keung Lau Breakdown of academic impact, for papers by Annelisa Marsella
Rankless by CCL
2026